Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Medicine 13, 26–28 (1 January 2007) | doi:10.1038/nm0107-26
IL-23: a master regulator in Crohn disease
Abstract
An innovative genetic study in people and two other recent studies in mice uncover a key factor in the pathogenesis of inflammatory bowel disease (IBD). The research puts the spotlight on the pro-inflammatory cytokine interleukin (IL)-23 (refs.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
